CytomX Therapeutics's market cap is currently $63.87M. The company's EPS TTM is $0.169; its P/E ratio is 4.60; CytomX Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 101.21M	$ 53.16M	$ 69.57M	$ 100.36M	$ 57.49M
Gross Profit	$ 101.21M	$ 47.31M	$ 63.73M	$ 100.36M	$ 57.49M
Operating Income	$ -6.48M	$ -101.33M	$ -83.78M	$ -48.60M	$ -110.89M
EBITDA	$ -4.31M	$ -98.89M	$ -113.34M	$ -77.97M	$ -138.88M
Net Income	$ -569.00K	$ -97.30M	$ -80.65M	$ -32.88M	$ -102.24M
Balance Sheet
Cash & Short-Term Investments	$ 174.51M	$ 193.65M	$ 305.23M	$ 316.12M	$ 296.14M
Total Assets	$ 201.79M	$ 260.89M	$ 339.41M	$ 358.66M	$ 341.28M
Total Debt	$ 13.97M	$ 18.06M	$ 18.06M	$ 24.87M	$ 24.87M
Net Debt	$ -3.20M	$ -175.59M	$ -187.47M	$ -166.99M	$ -163.55M
Total Liabilities	$ 249.24M	$ 346.64M	$ 250.03M	$ 308.86M	$ 290.17M
Stockholders' Equity	$ -47.45M	$ -85.75M	$ 89.38M	$ 49.80M	$ 51.11M
Cash Flow
Free Cash Flow	$ -56.88M	$ -112.53M	$ -120.64M	$ 2.95M	$ -143.98M
Operating Cash Flow	$ -56.03M	$ -110.79M	$ -119.03M	$ 5.26M	$ -140.48M
Investing Cash Flow	$ -150.67M	$ 98.26M	$ 22.49M	$ -18.72M	$ 79.70M
Financing Cash Flow	$ 30.23M	$ 648.00K	$ 110.21M	$ 16.89M	$ 1.63M

Currency in USD

CytomX Therapeutics Earnings and Revenue History

Income Statement >

CytomX Therapeutics Debt to Assets

Balance Sheet >

CytomX Therapeutics Cash Flow

Cash Flow >

CytomX Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing